Uploaded via media manager.

ARC’s successful Diabetic Retinal Screening program featured in national publication

The new IRIS (Intelligent Retinal Imaging Systems) program currently screening diabetes patients in three ARC clinics has received recognition in Ophthalmology Management, an online industry publication. Dr. Anas Daghestani, Chief of ARC Internal Medicine and Director of Population Health and Clinical Quality, explains how and why the program has been successful in “helping to prevent the preventable” eye disease. An excerpt of his findings is below. Read his conclusion it it’s entirety here.

Helping to prevent the preventable

A primary care group learns that to detect diabetic retinopathies early, making the detection process convenient is vital.

By Anas Daghestani, MD

Diabetic retinopathy threatens the vision of more than 5 million U.S. adults over age 40. The leading cause of blindness in this country, diabetic retinopathy can affect anyone diagnosed with type 1 or type 2 diabetes, so blindness is a real possibility for millions of Americans. While diabetic retinopathy is highly treatable if caught early, data suggest fewer than half of diabetics keep up with the recommended annual eye screening.

Our primary care group has seen similar lackluster screening numbers among our diabetic patients. Despite years of proactive efforts — using electronic medical record alerts, mailing letters, making phone calls and delivering nagging in-person reminders — we barely moved the needle from a 45% compliance rate.

Our staff members wanted to change this dynamic and convince patients to get screened. It was only because of advancements in technology that we found a way to achieve it….

Continued at ophthalmologymanagement.com

Related: New Screening Saves Vision, Prevents Blindness

Tags: Dr. Anas Daghestani, Diabetic retinopathy, diabetes, vision

More on this Topic

How ARC is Using New Eye Screening Technology to Prevent Blindness Disease

Less than half of diabetic adults do not get their annual eye screening, putting them at risk for diabetic retinopathy, one of the leading causes of blindness. ARC knew it could do better. That is why they brought the technology to its patients. The results have been outstanding. More on KXAN-TV.

New Screening Saves Vision, Prevents Blindness

Diabetic retinopathy is the leading cause of blindness in the U.S., but has few early symptoms. You can now get a retinal eye screening at your next visit.

A 5-minute scan can save your eyesight

Diabetic retinopathy is the leading cause of blindness in all adults under the age of 75 but it is also detectable and treatable. ARC has a vision-saving scan.

In-Office Eye Screening Leads to Improved Diabetic Eye Health

Stella N., who has been an ARC patient since 2002, was diagnosed with diabetes in the 1980's. In 2015, when she saw her regular ARC physician, Dr. Sharon Liu, Stella expected to be referred to an ophthalmologist for an eye screening but she got a surprise. 

ARC Diabetic Patients to Benefit From New Eye Screening Technology

ARC has installed eye screening telemedicine technology at three of its locations to help prevent the eye disease known as diabetic retinopathy, the leading cause of blindness among U.S. adults. The goal is simple…identify disease symptoms early and prevent blindness by making it convenient for patients to access eye screenings. It’s what’s right for our patients.